Annual Current Assets
$233.92 M
-$116.24 M-33.20%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual total current assets is $233.92 million, with the most recent change of -$116.24 million (-33.20%) on December 31, 2023.
- During the last 3 years, KPTI annual current assets has fallen by -$42.61 million (-15.41%).
- KPTI annual current assets is now -33.20% below its all-time high of $350.16 million, reached on December 31, 2022.
Performance
KPTI Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$184.75 M
-$23.79 M-11.41%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly total current assets is $184.75 million, with the most recent change of -$23.79 million (-11.41%) on September 30, 2024.
- Over the past year, KPTI quarterly current assets has dropped by -$23.79 million (-11.41%).
- KPTI quarterly current assets is now -50.19% below its all-time high of $370.92 million, reached on March 31, 2020.
Performance
KPTI Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
KPTI Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.2% | -11.4% |
| 3 y3 years | -15.4% | -23.5% |
| 5 y5 years | -30.1% | -34.2% |
KPTI Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.2% | at low | -47.2% | at low |
| 5 y | 5-year | -33.2% | at low | -50.2% | at low |
| alltime | all time | -33.2% | >+9999.0% | -50.2% | >+9999.0% |
Karyopharm Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $184.75 M(-11.4%) |
| Jun 2024 | - | $208.54 M(+5.1%) |
| Mar 2024 | - | $198.37 M(-15.2%) |
| Dec 2023 | $6.52 M(-18.6%) | $233.92 M(-11.1%) |
| Sep 2023 | - | $263.22 M(-9.7%) |
| Jun 2023 | - | $291.38 M(-8.5%) |
| Mar 2023 | - | $318.54 M(-9.0%) |
| Dec 2022 | $8.01 M(-73.0%) | $350.16 M(+57.3%) |
| Sep 2022 | - | $222.68 M(-8.2%) |
| Jun 2022 | - | $242.45 M(-12.3%) |
| Mar 2022 | - | $276.53 M(+0.3%) |
| Dec 2021 | $29.70 M(-18.7%) | $275.61 M(+14.1%) |
| Sep 2021 | - | $241.58 M(-11.7%) |
| Jun 2021 | - | $273.50 M(+7.0%) |
| Mar 2021 | - | $255.51 M(-7.6%) |
| Dec 2020 | $36.52 M(+122.8%) | $276.53 M(-3.1%) |
| Sep 2020 | - | $285.45 M(-10.2%) |
| Jun 2020 | - | $317.84 M(-14.3%) |
| Mar 2020 | - | $370.92 M(+33.2%) |
| Dec 2019 | $16.39 M(+149.1%) | $278.57 M(-0.8%) |
| Sep 2019 | - | $280.87 M(+26.0%) |
| Jun 2019 | - | $222.83 M(-17.9%) |
| Mar 2019 | - | $271.44 M(-18.9%) |
| Dec 2018 | $6.58 M | $334.61 M(+58.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $211.56 M(-13.5%) |
| Jun 2018 | - | $244.56 M(+83.4%) |
| Mar 2018 | - | $133.31 M(-10.2%) |
| Dec 2017 | $31.87 M(-34.6%) | $148.42 M(+22.0%) |
| Sep 2017 | - | $121.68 M(-16.5%) |
| Jun 2017 | - | $145.72 M(+29.8%) |
| Mar 2017 | - | $112.23 M(-14.7%) |
| Dec 2016 | $48.75 M(+28.8%) | $131.64 M(+1.1%) |
| Sep 2016 | - | $130.25 M(+4.9%) |
| Jun 2016 | - | $124.20 M(-10.1%) |
| Mar 2016 | - | $138.14 M(-22.2%) |
| Dec 2015 | $37.84 M(+200.7%) | $177.60 M(-10.5%) |
| Sep 2015 | - | $198.34 M(-11.9%) |
| Jun 2015 | - | $225.25 M(-9.7%) |
| Mar 2015 | - | $249.32 M(+20.0%) |
| Dec 2014 | $12.59 M(+4561.5%) | $207.75 M(-10.2%) |
| Sep 2014 | - | $231.35 M(+71.0%) |
| Jun 2014 | - | $135.28 M(-8.3%) |
| Mar 2014 | - | $147.57 M(-6.6%) |
| Dec 2013 | $270.00 K(-24.4%) | $157.96 M(+194.8%) |
| Sep 2013 | - | $53.59 M(-13.8%) |
| Jun 2013 | - | $62.19 M(+6418.8%) |
| Dec 2012 | $357.00 K(-0.3%) | $954.00 K |
| Dec 2011 | $358.00 K | - |
FAQ
- What is Karyopharm Therapeutics annual total current assets?
- What is the all time high annual current assets for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual current assets year-on-year change?
- What is Karyopharm Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly current assets year-on-year change?
What is Karyopharm Therapeutics annual total current assets?
The current annual current assets of KPTI is $233.92 M
What is the all time high annual current assets for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual total current assets is $350.16 M
What is Karyopharm Therapeutics annual current assets year-on-year change?
Over the past year, KPTI annual total current assets has changed by -$116.24 M (-33.20%)
What is Karyopharm Therapeutics quarterly total current assets?
The current quarterly current assets of KPTI is $184.75 M
What is the all time high quarterly current assets for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly total current assets is $370.92 M
What is Karyopharm Therapeutics quarterly current assets year-on-year change?
Over the past year, KPTI quarterly total current assets has changed by -$23.79 M (-11.41%)